Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the...
-
Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3’s advancement toward clinical-stage immunotherapy development SAB...
-
Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI...
-
Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB: AVAI), Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Viking Therapeutics,...
-
Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "2025 Protein Synthesis Research Review" report has been added to ResearchAndMarkets.com's offering.Key Market Valuations: The global market for...
-
SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the...
-
New York City, NY, April 22, 2026 (GLOBE NEWSWIRE) -- In an era where cognitive performance is directly linked to productivity, decision-making, and overall quality of life, advanced nootropic...
-
New York, USA, April 22, 2026 (GLOBE NEWSWIRE) -- Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight The polycythemia vera market is set for...
-
Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "IoT Medical Devices Market by Device Type, Component, Connectivity Technology, Application, and End User - Global Forecast to 2036" report has been...
-
Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the basal forebrain is reversible Findings also correlate...